Assessment of Additional Consolidation Chemotherapy Effects in Patients with Acute Myeloid Leukemia before Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Ghavamzadeh, Ardeshir [1 ]
Moghaddam, K. Ali [1 ]
Vaezi, M. [1 ]
Zafari, Y. [1 ]
Maheriazar, R. [1 ]
Mousavi, A. [1 ]
Bahar, B. [1 ]
Jahani, M. [1 ]
机构：
[1] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.453
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
407
引用
收藏
页码：S285 / S286
页数：2
相关论文
共 50 条
  • [41] Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience
    O'Hare, P.
    Lucchini, G.
    Cummins, M.
    Veys, P.
    Potter, M.
    Lawson, S.
    Vora, A.
    Wynn, R.
    Peniket, A.
    Kirkland, K.
    Pearce, R.
    Perry, J.
    Amrolia, P. J.
    BONE MARROW TRANSPLANTATION, 2017, 52 (06) : 825 - 831
  • [42] Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation
    Bommer, Martin
    von Harsdorf, Stephanie
    Doehner, Hartmut
    Bunjes, Donald
    Ringhoffer, Mark
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (11): : 1969 - 1972
  • [43] Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
    Wysocka-Slowik, Aleksandra
    Gil, Lidia
    Slebioda, Zuzanna
    Dorocka-Bobkowska, Barbara
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2021, 26 (05): : E642 - E650
  • [44] Allogeneic Stem Cell Transplantation for Refractory Acute Myeloid Leukemia in Pediatric Patients: The UK Experience
    O'Hare, Patricia M.
    Lucchini, Giovanna
    Cummins, Michelle
    Veys, Paul
    Potter, Mike
    Lawson, Sarah
    Vora, Ajay J.
    Wynn, Robert
    Peniket, Andrew
    Kirkland, Keiren
    Pearce, Rachel
    Perry, Julia
    Amrolia, Persis Jal
    BLOOD, 2015, 126 (23)
  • [45] Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation
    Yoshimoto, Goichi
    Mori, Yasuo
    Kato, Koji
    Odawara, Jun
    Kuriyama, Takuro
    Ueno, Toshiyuki
    Obara, Teppei
    Yurino, Ayano
    Yoshida, Shuro
    Ogawa, Ryosuke
    Ohno, Yuju
    Iwasaki, Hiromi
    Eto, Tetsuya
    Akashi, Koichi
    Miyamoto, Toshihiro
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 2939 - 2948
  • [46] The Optimal Time for Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia
    Bondarenko, Sergey
    Moiseev, Ivan
    Morozova, Elena
    Pirogova, Olga
    Darskaya, Elena
    Smirnova, Anna
    Tsvetkov, Nikolai
    Beynarovich, Anastasiya
    Samorodova, Irina
    Gindina, Tatyana
    Babenko, Elena
    Barkhatov, Ildar
    Alyanskiy, Alexander
    Kulagin, Alexander
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 209 - 210
  • [47] Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission
    Yeshurun, Moshe
    Labopin, Myriam
    Blaise, Didier
    Cornelissen, Jan J.
    Sengeloev, Henrik
    Vindelov, Lars
    Kuball, Juergen
    Chevallier, Patrice
    Craddock, Charles
    Socie, Gerard
    Bilger, Karin
    Schouten, Harry C.
    Fegueux, Nathalie
    Goker, Hakan
    Maertens, Johan
    Bunjes, Donald
    Arnold, Renate
    Nagler, Arnon
    Mohty, Mohamad
    CANCER, 2014, 120 (06) : 855 - 863
  • [48] Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease
    Yamasaki, Satoshi
    Aoki, Jun
    Mori, Jinichi
    Mizuno, Shohei
    Uchida, Naoyuki
    Ohashi, Kazuki
    Fukuda, Takahiro
    Ikegame, Kazuhiro
    Eto, Tetsuya
    Ogawa, Yukiyasu
    Tanaka, Masatsugu
    Hidaka, Michihiro
    Iwato, Koji
    Sawa, Masashi
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Yanada, Masamitsu
    Yano, Shingo
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 249 - 252
  • [49] Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease
    Satoshi Yamasaki
    Jun Aoki
    Jinichi Mori
    Shohei Mizuno
    Naoyuki Uchida
    Kazuki Ohashi
    Takahiro Fukuda
    Kazuhiro Ikegame
    Tetsuya Eto
    Yukiyasu Ogawa
    Masatsugu Tanaka
    Michihiro Hidaka
    Koji Iwato
    Masashi Sawa
    Tatsuo Ichinohe
    Yoshinobu Kanda
    Yoshiko Atsuta
    Masamitsu Yanada
    Shingo Yano
    Bone Marrow Transplantation, 2020, 55 : 249 - 252
  • [50] Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Dominietto, Alida
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) : 381 - 387
12345